HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated letters from lawmakers outlining the threats to innovation posed by mass firings at U.S. health agencies. More: In letter to RFK Jr., Democrats flag threats
read more
It is hoped that the approach will lead to more targeted treatments for childhood cancers More: ICR researchers develop blood test to uncover how childhood tumours adapt Source: News
read moreLooking to avoid a repeat of the shortages that plagued Mounjaro and Zepbound during their initial rollouts, Eli Lilly is building supply of its oral GLP-1 contender orforglipron well before the drug’s expected approval in 2026. More: Lilly banks stockpile
read moreRevenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. Of the world’s 22 biopharma companies that have reported quarterly revenues of at least $2 billion, only one
read moreGranules shelled out a reported 20 million Swiss francs ($22.3 million) to acquire Swiss CDMO Senn Chemicals. The move positions the Hyderabad, India-based drug manufacturer to enter the booming peptides production business being driven by innovative weight-loss drugs. More: India’s
read more© 1994 - 2025 B.M. Pharmaceuticals